Literature DB >> 1945351

The effects of the Medicare PPS on vulnerable subgroups of psychiatric patients treated in short-term general hospitals.

S I DesHarnais1, D Schumacher.   

Abstract

Changes in care in short-term general hospitals were monitored for three vulnerable subgroups of Medicare psychiatric patients: (1) those more than 75 years old, (2) those with comorbidities, and (3) those with one or more secondary diagnoses of psychiatric or substance abuse problems. Patterns of care studied for changes following institution of the Medicare Prospective Payment System (PPS) were volume of cases, average length of stay, discharge locations, and readmission rates. Results indicate that the changes occurring for the three subgroups were similar to the changes occurring for all Medicare psychiatric patients. After PPS was introduced in 1983, the average length of stay decreased, and a greater proportion of patients were discharged to other hospitals or home health care providers; however, rates of readmission to the same hospital did not increase.

Entities:  

Mesh:

Year:  1991        PMID: 1945351     DOI: 10.1016/s0097-5990(16)30466-3

Source DB:  PubMed          Journal:  QRB Qual Rev Bull        ISSN: 0097-5990


  2 in total

1.  Characteristics of high staff intensive Medicare psychiatric inpatients.

Authors:  Jerry Cromwell; Jan Maier; Barbara Gage; Edward Drozd; Deborah Osber; Erin Richter; Leslie Greenwald; Howard Goldman
Journal:  Health Care Financ Rev       Date:  2004

Review 2.  Activity-based funding of hospitals and its impact on mortality, readmission, discharge destination, severity of illness, and volume of care: a systematic review and meta-analysis.

Authors:  Karen S Palmer; Thomas Agoritsas; Danielle Martin; Taryn Scott; Sohail M Mulla; Ashley P Miller; Arnav Agarwal; Andrew Bresnahan; Afeez Abiola Hazzan; Rebecca A Jeffery; Arnaud Merglen; Ahmed Negm; Reed A Siemieniuk; Neera Bhatnagar; Irfan A Dhalla; John N Lavis; John J You; Stephen J Duckett; Gordon H Guyatt
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.